LSD1 inhibitor enhances CD8+ T cell migration which was blocked by concurrent treatment with siRNA or inhibitor of chemokine receptors on T cells, indicating a critical role of LSD1 in governing CD8+ lymphocyte trafficking to the tumor cluster (61). This evidence concerns the gene KDM1A and neoplasm.